Plant ID: NPO992
Plant Latin Name: Betula alnoides
Taxonomy Genus: Betula
Taxonomy Family: Betulaceae
NCBI TaxonomyDB:
284673
Plant-of-the-World-Online:
295031-1
Antidote; Antiseborrheic
Bangladesh; Myanmar; Nepal; India; Vietnam; China; Laos; Thailand
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Oxidoreductase | HMGCR | HMG-CoA reductase | P04035 | CHEMBL402 |
Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.287E-11 | 4.203E-07 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.841E-10 | 2.788E-06 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.997E-09 | 8.696E-06 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 2.210E-08 | 6.407E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 2.942E-08 | 6.407E-05 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.731E-08 | 6.407E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 6.714E-08 | 9.747E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 4.823E-07 | 5.528E-04 | CYP1A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 1.240E-06 | 1.350E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.406E-06 | 1.457E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 2.250E-06 | 2.227E-03 | CYP1A1, CYP1A2 |
BP | GO:0050896; response to stimulus | GO:0009636; response to toxic substance | 2.682E-06 | 2.336E-03 | CNR2, CYP1A1, CYP1B1, HMGCR |
BP | GO:0008152; metabolic process | GO:0016125; sterol metabolic process | 5.603E-06 | 3.697E-03 | CYP19A1, CYP1B1, HMGCR |
BP | GO:0009987; cellular process | GO:0071280; cellular response to copper ion | 6.262E-06 | 4.011E-03 | CYP1A1, CYP1A2 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.614E-03 | 5.658E-01 | CYP1A1, CYP1A2, CYP1B1, HMGCR |
CC | GO:0044464; cell part | GO:0031234; extrinsic component of cytoplasmic side of plasma membrane | 2.216E-02 | 1.000E+00 | CNR2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 9.508E-10 | 1.426E-08 | CYP1A2, CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.476E-07 | 1.107E-06 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 2.925E-07 | 1.462E-06 | CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.258E-07 | 3.472E-06 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.317E-06 | 3.950E-06 | CYP1A2, CYP1A1, CYP1B1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.988E-04 | 4.259E-04 | CYP1A2, CYP1A1, HMGCR, CYP19A1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.547E-04 | 3.868E-04 | CYP1A2, CYP1A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 8.670E-03 | 1.300E-02 | CYP1A2 |
09100 Metabolism | 09109 Metabolism of terpenoids and polyketides | hsa00900 | Terpenoid backbone biosynthesis | 6.583E-03 | 1.097E-02 | HMGCR |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.499E-03 | 2.811E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immune disorder | D80-D89 | CNR2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CNR2; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | CNR2; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | CNR2; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | CNR2; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | CNR2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoporosis | M80-M81, Z79.890 | CNR2; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | CNR2; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |